BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 579295)

  • 1. Prolactin oversuppression.
    Bohnet HG; Mühlenstedt D; Hanker JP; Schneider HP
    Arch Gynakol; 1977 Oct; 223(3):173-8. PubMed ID: 579295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels and bromocriptine treatment of short luteal phase.
    Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
    Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Luteal insufficiency as a prolactin-related disorder of the menstrual cycle].
    Bohnet HG
    Fortschr Med; 1980 Nov; 98(41):1618-23. PubMed ID: 6781997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment with bromoergocryptine in functional infertility caused by corpus luteum insufficiency].
    Apró G; Godó G; Sas M
    Zentralbl Gynakol; 1983; 105(8):473-7. PubMed ID: 6868875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of bromocriptine treatment on prolactin secretion in infertile women with suspicion of luteal phase insufficiency].
    Krzemiński A; Sikorski R; Woźniak S
    Ginekol Pol; 1998 Dec; 69(12):1141-5. PubMed ID: 10224791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the prolactin inhibitor bromocriptin (CB 154) on human luteal function in vivo.
    Schulz KD; Geiger W; Del Pozo E; Lose KH; Künzig HJ; Lancranjan I
    Arch Gynakol; 1976 Sep; 221(2):93-6. PubMed ID: 990059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of hyperprolactinemic infertility with ovulatory disturbances.
    Borenstein R; Katz Z; Lancet M; Caspi B; Ben-David M
    Int J Gynaecol Obstet; 1980; 18(3):195-9. PubMed ID: 6109654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolactin and bromocriptine on the luteal phase in infertile women.
    Fredricsson B; Carlström K; Björk G; Messinis I
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):319-33. PubMed ID: 6785120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum progesterone and endometrial biopsy for confirmation of ovulation and evaluation of luteal function.
    Shepard MK; Senturia YD
    Fertil Steril; 1977 May; 28(5):541-8. PubMed ID: 856637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patients.
    Bennink HJ
    Fertil Steril; 1979 Mar; 31(3):267-72. PubMed ID: 571359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin and deficient luteal function.
    del Pozo E; Wyss H; Tollis G; Alcañiz J; Campana A; Naftolin F
    Obstet Gynecol; 1979 Mar; 53(3):282-6. PubMed ID: 424097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.